Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry

Background: It is uncertain whether exposure to renin–angiotensin system (RAS) modifiers affects the severity of the new coronavirus disease 2019 (COVID-19) because most of the available studies are retrospective. Methods: We tested the prognostic value of exposure to RAS modifiers (either angiotens...

Descripción completa

Detalles Bibliográficos
Autores principales: Angeli, Fabio, Verdecchia, Paolo, Balestrino, Antonella, Bruschi, Claudio, Ceriana, Piero, Chiovato, Luca, Dalla Vecchia, Laura Adelaide, Fanfulla, Francesco, La Rovere, Maria Teresa, Perego, Francesca, Scalvini, Simonetta, Spanevello, Antonio, Traversi, Egidio, Visca, Dina, Vitacca, Michele, Bachetti, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781822/
https://www.ncbi.nlm.nih.gov/pubmed/35050225
http://dx.doi.org/10.3390/jcdd9010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781822/
https://www.ncbi.nlm.nih.gov/pubmed/35050225
http://dx.doi.org/10.3390/jcdd9010015

Ejemplares similares